Substituted thiazolo[5,4-d]pyrimidine urea derivatives
US7947692B2 · kind B2 · utility
13Cited by
1References
41Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 11, 2007 |
| Grant date | May 24, 2011 |
| Priority date | — |
| Expiry date | Apr 23, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D521/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There are presented compounds of the formulaor a pharmaceutically acceptable salt thereof, which are active adenosine A2B receptor antagonists and useful in the treatment of diabetes, diabetic retinopathy, asthma and diarrhea.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.